
Image from fleetcarma.com
A £25million funding competition from the Industrial Strategy Challenge Fund will be available to innovative businesses with projects to develop batteries for future electric vehicles.
The Faraday battery challenge is a £246 million investment to bring forward the next generation of electric vehicles. These will be powered by high-performance EV batteries that are cost-effective, lightweight, durable and safe, and can be recycled.
Funding details
This competition is to support business-led research and development to improve batteries for automotive applications.
There are 2 opportunities to apply, depending on the stage of your project, which are:
- up to £23 million for industrial research and development
- up to £2 million for feasibility studies
In both opportunities projects should aim to:
- make it easier to scale up battery production and use
- build the UK supply chain
Please see below a summary of the funding details:
Competition opens : 17 September 2018
Deadline : 12 December 2018
Lead : UK-based business OR research and technology organisation (in collaboration with other businesses, academic organisations, charities, public sector or research and technology organisations)
Available award : between £500,000 and £15million
Project duration : between 3 and 18 months
Please see this link for more information about this funding opportunity.
ISCF Faraday Battery Challenge: Faraday Institution – Battery Characterisation Call
Testing connected and autonomous vehicles: funding available










Join the 17th Annual Postgraduate Research Conference – Wednesday 3 December 2025
BU Festival of Social Sciences invite at RNLI
MaGPIE Presents at UK Parliament: From Mass Graves to Courtroom
ECR Funding Open Call: Research Culture & Community Grant – Apply Now
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease